| Primary |
| Hiv Infection |
68.4% |
| Tuberculosis |
5.1% |
| Prophylaxis |
4.6% |
| Urticaria |
3.5% |
| Hypertension |
2.3% |
| Pulmonary Tuberculosis |
2.1% |
| Antiretroviral Therapy |
1.6% |
| Depression |
1.6% |
| Liver Transplant |
1.2% |
| Prophylaxis Against Transplant Rejection |
1.2% |
| Transplant |
1.2% |
| Chemotherapy |
0.9% |
| Deep Vein Thrombosis |
0.9% |
| Insomnia |
0.9% |
| Myocardial Infarction |
0.9% |
| Acquired Immunodeficiency Syndrome |
0.7% |
| Antifungal Prophylaxis |
0.7% |
| Immunosuppressant Drug Therapy |
0.7% |
| Product Used For Unknown Indication |
0.7% |
| Pyrexia |
0.7% |
|
| Sepsis |
12.2% |
| Vomiting |
10.2% |
| Weight Decreased |
8.2% |
| Progressive External Ophthalmoplegia |
6.1% |
| Renal Failure Acute |
6.1% |
| Death |
4.1% |
| Deep Vein Thrombosis |
4.1% |
| Hepatocellular Injury |
4.1% |
| Hepatotoxicity |
4.1% |
| Multi-organ Failure |
4.1% |
| Neutropenia |
4.1% |
| Pneumonia Bacterial |
4.1% |
| Pulmonary Tuberculosis |
4.1% |
| Rash Maculo-papular |
4.1% |
| Rhabdomyolysis |
4.1% |
| Toxic Epidermal Necrolysis |
4.1% |
| Vena Cava Thrombosis |
4.1% |
| Visual Impairment |
4.1% |
| Acute Hepatitis B |
2.0% |
| Adverse Event |
2.0% |
|
| Secondary |
| Hiv Infection |
44.0% |
| Drug Use For Unknown Indication |
28.0% |
| Product Used For Unknown Indication |
10.0% |
| Pathogen Resistance |
3.9% |
| Prophylaxis |
1.9% |
| Depression |
1.5% |
| Mycobacterium Avium Complex Infection |
1.5% |
| Diffuse Large B-cell Lymphoma |
1.0% |
| Hepatitis C |
1.0% |
| Pulmonary Tuberculosis |
1.0% |
| Pyrexia |
1.0% |
| Liver Transplant |
0.8% |
| Tuberculosis |
0.8% |
| Cardiomyopathy |
0.6% |
| Hypertension |
0.6% |
| Pneumonia |
0.6% |
| Aids |
0.4% |
| Antiretroviral Therapy |
0.4% |
| Anxiety |
0.4% |
| Contraception |
0.4% |
|
| Weight Decreased |
37.5% |
| Proteinuria |
10.4% |
| Pain |
6.3% |
| Thrombocytopenia |
6.3% |
| Drug Resistance |
4.2% |
| Multi-organ Failure |
4.2% |
| Suicidal Ideation |
4.2% |
| Blood Creatine Phosphokinase Increased |
2.1% |
| Blood Potassium Decreased |
2.1% |
| Death |
2.1% |
| Gastritis |
2.1% |
| Hepatocellular Injury |
2.1% |
| Hypersensitivity |
2.1% |
| Immune Reconstitution Inflammatory Syndrome Associated Kaposi's Sarcoma |
2.1% |
| Immune Reconstitution Syndrome |
2.1% |
| Latent Autoimmune Diabetes In Adults |
2.1% |
| Legionella Infection |
2.1% |
| Leukocytoclastic Vasculitis |
2.1% |
| Lipase Increased |
2.1% |
| Local Swelling |
2.1% |
|
| Concomitant |
| Hiv Infection |
56.9% |
| Product Used For Unknown Indication |
7.8% |
| Drug Use For Unknown Indication |
5.1% |
| Asthma |
3.0% |
| Hypertension |
3.0% |
| Antifungal Prophylaxis |
2.7% |
| Infection Prophylaxis |
2.7% |
| Prophylaxis |
2.7% |
| Bronchopulmonary Aspergillosis |
1.8% |
| Cerebral Toxoplasmosis |
1.5% |
| Diarrhoea |
1.5% |
| Liver Disorder |
1.5% |
| Analgesia |
1.2% |
| Antibiotic Prophylaxis |
1.2% |
| Cytomegalovirus Chorioretinitis |
1.2% |
| Hepatitis B |
1.2% |
| Hepatitis C |
1.2% |
| Histiocytosis Haematophagic |
1.2% |
| Hiv Test Positive |
1.2% |
| Osteoporosis |
1.2% |
|
| Hepatic Steatosis |
15.0% |
| Platelet Count Decreased |
12.5% |
| Respiratory Arrest |
10.0% |
| Spinal Compression Fracture |
10.0% |
| Osteoporosis |
7.5% |
| Hypophosphataemia |
5.0% |
| Pneumonia Bacterial |
5.0% |
| Pneumothorax |
5.0% |
| Abortion Induced |
2.5% |
| Angina Pectoris |
2.5% |
| Bronchopulmonary Aspergillosis |
2.5% |
| Dizziness |
2.5% |
| Large Intestine Polyp |
2.5% |
| Liver Function Test Abnormal |
2.5% |
| Memory Impairment |
2.5% |
| Meningitis Tuberculous |
2.5% |
| Neutrophil Count Decreased |
2.5% |
| Oedema Peripheral |
2.5% |
| Pneumonia |
2.5% |
| Pyrexia |
2.5% |
|
